| Code | Description | Claims | Beneficiaries | Total Paid |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
10,962 |
4,641 |
$322K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
9,498 |
7,786 |
$267K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
5,123 |
5,035 |
$157K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,640 |
6,581 |
$147K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,094 |
4,919 |
$123K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12,672 |
4,700 |
$97K |
| 87631 |
|
1,121 |
560 |
$50K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
216 |
188 |
$23K |
| 86328 |
|
332 |
323 |
$13K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
882 |
597 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
176 |
176 |
$8K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
56 |
55 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
33 |
32 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
66 |
66 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
24 |
24 |
$982.08 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
33 |
33 |
$386.16 |
| 99307 |
|
24 |
13 |
$328.80 |
| 99072 |
|
29 |
29 |
$0.00 |